Last reviewed · How we verify

NCT04848103

Effect of Extracorporeal Shock Wave Therapy After Arthroscopic Rotator Cuff Repair

Completed NA Last updated 13 July 2021
What this trial tests

NA trial testing Radial extracorporeal shockwave therapy in Rotator Cuff Injuries in 30 participants. Completed in 8 July 2021.

Timeline
10 May 2021
Primary endpoint
30 June 2021
8 July 2021

Quick facts

Lead sponsorSahmyook University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date10 May 2021
Primary completion30 June 2021
Estimated completion8 July 2021
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Sahmyook University

Who can join

Adults 19 to 65, any sex, with Rotator Cuff Injuries or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although radial extracorporeal shock wave therapy (rESWT) has proven to be an effective treatment, the effectiveness of the treatment has so far been controversial. There are no studies using rESWT in rehabilitation after arthroscopic rotator cuff repair (ARCR). Therefore, in this study, there is evidence that rESWT promotes pain control and healing recovery, and through previous studies, we would like to investigate whether treatment with rESWT during the intensive rehabilitation period of patients after ARCR is more effective in controlling pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of radial extracorporeal shockwave therapy in rehabilitation following arthroscopic rotator cuff repair: A STROBE compliant study.
    Kim HJ, Choi W, Jung J, Park S, et al · · 2022 · cited 5× · PMID 36107497 · DOI 10.1097/md.0000000000030053

Verify or expand the search:

Other recruiting trials for Rotator Cuff Injuries

Currently open trials in the same condition.

Other Sahmyook University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04848103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing